Lipid peroxidation and neurodegenerative disease

Free Radical Biology and Medicine

Volumn 51, Issue 7, 2011, Pages 1302-1319

  Reed, Tanea T ^a  

^a EASTERN KENTUCKY UNIVERSITY   (United States)

Author keywords

4 Hydroxynonenal; Alzheimer disease; Amyotrophic lateral sclerosis; Free radicals; Huntington disease; Lipid peroxidation; Neurodegenerative disease; Parkinson disease; Proteomics

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; ISOPROSTANE DERIVATIVE; NEUROPROSTANE; OXYGEN RADICAL; POLYUNSATURATED FATTY ACID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CHEMICAL STRUCTURE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; HUNTINGTON CHOREA; LIPID PEROXIDATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

ALDEHYDES; ANIMALS; BIOLOGICAL MARKERS; ENERGY METABOLISM; FATTY ACIDS, UNSATURATED; FREE RADICALS; HUMANS; ISOPROSTANES; LIPID PEROXIDATION; MICE; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEUROPROSTANES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOMICS; RATS; SEVERITY OF ILLNESS INDEX;

EID: 80052261937     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.06.027     Document Type: Review

References (306)

1. E. Schauenstein, and H. Esterbauer Formation and properties of reactive aldehydes Ciba Found. Symp. 67 1978 225 244
2. A. Benedetti, M. Comporti, and H. Esterbauer Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids Biochim. Biophys. Acta 620 1980 281 296 (Pubitemid 11216247)
3. P. Winkler, W. Lindner, H. Esterbauer, E. Schauenstein, R.J. Schaur, and G.A. Khoschsorur Detection of 4-hydroxynonenal as a product of lipid peroxidation in native Ehrlich ascites tumor cells Biochim. Biophys. Acta 796 1984 232 237 (Pubitemid 15158769)
4. G. Khoschsorur, R.J. Schaur, E. Schauenstein, H.M. Tillian, and M. Reiter Intracellular effect of hydroxyalkenals on animal tumors (author's transl) Z. Naturforsch. C 36 1981 572 578
5. E. Wawra, H. Zollner, R.J. Schaur, H.M. Tillian, and E. Schauenstein The inhibitory effect of 4-hydroxy-nonenal on DNA-polymerases alpha and beta from rat liver and rapidly dividing Yoshida ascites hepatoma Cell Biochem. Funct. 4 1986 31 36 (Pubitemid 16177887)
6. J. Lang, C. Celotto, and H. Esterbauer Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high-performance liquid chromatography Anal. Biochem. 150 1985 369 378 (Pubitemid 16201201)
7. G. Jurgens, J. Lang, and H. Esterbauer Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal Biochim. Biophys. Acta 875 1986 103 114 (Pubitemid 16154787)
8. H.F. Hoff, J. O'Neil, G.M. Chisolm III, T.B. Cole, O. Quehenberger, H. Esterbauer, and G. Jurgens Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages Arteriosclerosis 9 1989 538 549 (Pubitemid 19184488)
9. M.A. Rossi, A. Garramone, and M.U. Dianzani Stimulation of phospholipase C activity by 4-hydroxynonenal; influence of GTP and calcium concentration Int. J. Tissue React. 10 1988 321 325 (Pubitemid 19129903)
10. W.K. Subczynski, and J.S. Hyde Concentration of oxygen in lipid bilayers using a spin-label method Biophys. J. 41 1983 283 286
11. R.M. Adibhatla, and J.F. Hatcher Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies BMB Rep. 41 2008 560 567
12. J. Qin, R. Goswami, R. Balabanov, and G. Dawson Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain J. Neurosci. Res. 85 2007 977 984 (Pubitemid 46580339)
13. E. Cadenas, A. Muller, R. Brigelius, H. Esterbauer, and H. Sies Effects of 4-hydroxynonenal on isolated hepatocytes: studies on chemiluminescence response, alkane production and glutathione status Biochem. J. 214 1983 479 487 (Pubitemid 13035530)
14. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128 (Pubitemid 121003917)
15. M. Fukuda, F. Kanou, N. Shimada, M. Sawabe, Y. Saito, S. Murayama, M. Hashimoto, N. Maruyama, and A. Ishigami Elevated levels of 4-hydroxynonenal- histidine Michael adduct in the hippocampi of patients with Alzheimer's disease Biomed. Res. 30 2009 227 233
16. D.V. Nadkarni, and L.M. Sayre Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal Chem. Res. Toxicol. 8 1995 284 291
17. N.Y. Calingasan, K. Uchida, and G.E. Gibson Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease J. Neurochem. 72 1999 751 756 (Pubitemid 29055239)
18. K.S. Montine, J.F. Quinn, J. Zhang, J.P. Fessel, L.J. Roberts II, J.D. Morrow, and T.J. Montine Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases Chem. Phys. Lipids 128 2004 117 124 (Pubitemid 38167381)
19. T.J. Montine, M.F. Beal, M.E. Cudkowicz, H. O'Donnell, R.A. Margolin, L. McFarland, A.F. Bachrach, W.E. Zackert, L.J. Roberts, and J.D. Morrow Increased CSF F2-isoprostane concentration in probable AD Neurology 52 1999 562 565 (Pubitemid 29075604)
20. L.J. Roberts II, and J.D. Morrow Isoprostanes: novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury Ann. N. Y. Acad. Sci. 744 1994 237 242 (Pubitemid 26005828)
21. J.D. Morrow, K.E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr, and L.J. Roberts II A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc. Natl. Acad. Sci. U.S.A. 87 1990 9383 9387 (Pubitemid 120030630)
22. L.J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am. J. Physiol. Lung Cell. Mol. Physiol. 280 2001 L1067 L1082 (Pubitemid 32553245)
23. L.J. Roberts II, and J.D. Morrow The generation and actions of isoprostanes Biochim. Biophys. Acta 1345 1997 121 135 (Pubitemid 27138414)
24. J.D. Morrow, and L.J. Roberts The isoprostanes: unique bioactive products of lipid peroxidation Prog. Lipid Res. 36 1997 1 21 (Pubitemid 27387112)
25. L.J. Roberts II, T.J. Montine, W.R. Markesbery, A.R. Tapper, P. Hardy, S. Chemtob, W.D. Dettbarn, and J.D. Morrow Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid J. Biol. Chem. 273 1998 13605 13612 (Pubitemid 28268404)
26. E.S. Musiek, J.D. Brooks, M. Joo, E. Brunoldi, A. Porta, G. Zanoni, G. Vidari, T.S. Blackwell, T.J. Montine, G.L. Milne, B. McLaughlin, and J.D. Morrow Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid J. Biol. Chem. 283 2008 19927 19935
27. S.S. Davies, V. Amarnath, K.S. Montine, N. Bernoud-Hubac, O. Boutaud, T.J. Montine, and L.J. Roberts II Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function FASEB J. 16 2002 715 717
28. A. Greco, L. Minghetti, and G. Levi Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases Neurochem. Res. 25 2000 1357 1364
29. 2-isoprostanes as an index of oxidative stress in vivo Free Radic. Biol. Med. 28 2000 505 513 (Pubitemid 30136031)
30. H. Esterbauer, H. Zollner, and J. Lang Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions Biochem. J. 228 1985 363 373 (Pubitemid 15061126)
31. R.A. Cooper Metabolism of methylglyoxal in microorganisms Annu. Rev. Microbiol. 38 1984 49 68
32. S.A. Phillips, and P.J. Thornalley The formation of methylglyoxal from triose phosphates: investigation using a specific assay for methylglyoxal Eur. J. Biochem. 212 1993 101 105 (Pubitemid 23064605)
33. C. Schneider, N.A. Porter, and A.R. Brash Autoxidative transformation of chiral omega6 hydroxy linoleic and arachidonic acids to chiral 4-hydroxy-2E-nonenal Chem. Res. Toxicol. 17 2004 937 941 (Pubitemid 38955353)
34. U.H. Danielson, H. Esterbauer, and B. Mannervik Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases Biochem. J. 247 1987 707 713
35. K. Uchida, and E.R. Stadtman Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase: a possible involvement of intra- and intermolecular cross-linking reaction J. Biol. Chem. 268 1993 6388 6393 (Pubitemid 23099334)
36. J.A. Doorn, and D.R. Petersen Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal Chem. Biol. Interact. 143-144 2003 93 100 (Pubitemid 36246435)
37. T.J. Montine, K.S. Montine, E.E. Reich, E.S. Terry, N.A. Porter, and J.D. Morrow Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes Biochem. Pharmacol. 65 2003 611 617 (Pubitemid 36144247)
38. H.C. Kuiper, R.S. Bruno, M.G. Traber, and J.F. Stevens Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans Free Radic. Biol. Med. 50 2011 848 853
39. K. Temma-Asano, E. Tskitishvili, T. Kanagawa, T. Tomimatsu, T. Tsutsui, T. Kimura, Y.S. Chang, T. Nakamura, Y. Nakai, K. Shimoya, Effects of 4-hydroxy-2-nonenal, a major lipid peroxidation-derived aldehyde, and N-acetylcysteine on the cyclooxygenase-2 expression in human uterine myometrium. Gynecol. Obstet. Invest. 72:37-42; 2011.
40. R. Subramaniam, F. Roediger, B. Jordan, M.P. Mattson, J.N. Keller, G. Waeg, and D.A. Butterfield The lipid peroxidation product, 4-hydroxy-2-trans- nonenal, alters the conformation of cortical synaptosomal membrane proteins J. Neurochem. 69 1997 1161 1169 (Pubitemid 27364837)
41. R.C. Siow, T. Ishii, and G.E. Mann Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway Redox Rep. 12 2007 11 15 (Pubitemid 46210347)
42. D.L. Vander Jagt, L.A. Hunsaker, T.J. Vander Jagt, M.S. Gomez, D.M. Gonzales, L.M. Deck, and R.E. Royer Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes Biochem. Pharmacol. 53 1997 1133 1140 (Pubitemid 27224259)
43. I. Juranek, L. Horakova, L. Rackova, and M. Stefek Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles Curr. Med. Chem. 17 2010 552 570
44. A.H. Tsang, and K.K. Chung Oxidative and nitrosative stress in Parkinson's disease Biochim. Biophys. Acta 1792 2009 643 650
45. V. Perez-De La Cruz, D. Elinos-Calderon, Y. Robledo-Arratia, O.N. Medina-Campos, J. Pedraza-Chaverri, S.F. Ali, and A. Santamaria Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease Behav. Brain Res. 199 2009 210 217
46. D. Galasko, and T.J. Montine Biomarkers of oxidative damage and inflammation in Alzheimer's disease Biomark. Med. 4 2010 27 36
47. M.J. Picklo, T.J. Montine, V. Amarnath, and M.D. Neely Carbonyl toxicology and Alzheimer's disease Toxicol. Appl. Pharmacol. 184 2002 187 197 (Pubitemid 35428851)
48. M.D. Neely, and T.J. Montine CSF lipoproteins and Alzheimer's disease J. Nutr. Health Aging 6 2002 383 391 (Pubitemid 36024782)
49. T. Reed, M. Perluigi, R. Sultana, W.M. Pierce, J.B. Klein, D.M. Turner, R. Coccia, W.R. Markesbery, and D.A. Butterfield Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease Neurobiol. Dis. 30 2008 107 120
50. C.D. Aluise, R.A. Robinson, T.L. Beckett, M.P. Murphy, J. Cai, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics Neurobiol. Dis. 39 2010 221 228
51. H. Esterbauer, H. Zollner, and N. Scholz Reaction of glutathione with conjugated carbonyls Z. Naturforsch. C 30 1975 466 473
52. K.V. Subbarao, J.S. Richardson, and L.C. Ang Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro J. Neurochem. 55 1990 342 345
53. D.T. Dexter, A.E. Holley, W.D. Flitter, T.F. Slater, F.R. Wells, S.E. Daniel, A.J. Lees, P. Jenner, and C.D. Marsden Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study Mov. Disord. 9 1994 92 97 (Pubitemid 24022621)
54. R.J. Ferrante, S.E. Browne, L.A. Shinobu, A.C. Bowling, M.J. Baik, U. MacGarvey, N.W. Kowall, R.H. Brown Jr. , and M.F. Beal Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis J. Neurochem. 69 1997 2064 2074 (Pubitemid 27452754)
55. S.E. Browne, R.J. Ferrante, and M.F. Beal Oxidative stress in Huntington's disease Brain Pathol. 9 1999 147 163 (Pubitemid 29056525)
56. S.J. Chinta, J.K. Mallajosyula, A. Rane, and J.K. Andersen Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo Neurosci. Lett. 486 2010 235 239
57. N.M. Bonini, and B.I. Giasson Snaring the function of alpha-synuclein Cell 123 2005 359 361
58. M. Shamoto-Nagai, W. Maruyama, Y. Hashizume, M. Yoshida, T. Osawa, P. Riederer, and M. Naoi In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity J. Neural Transm. 114 2007 1559 1567 (Pubitemid 350212012)
59. K.L. Lim Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies Expert Rev. Proteomics 4 2007 769 781
60. K. Zarkovic 4-Hydroxynonenal and neurodegenerative diseases Mol. Aspects Med. 24 2003 293 303 (Pubitemid 36945029)
61. E. Dalfo, and I. Ferrer Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases Neurobiol. Aging 29 2008 408 417 (Pubitemid 351222679)
62. + ATPase in rat striatal synaptosomes Neurochem. Int. 33 1998 531 540 (Pubitemid 29116229)
63. X. Li, E. Sapp, A. Valencia, K.B. Kegel, Z.H. Qin, J. Alexander, N. Masso, P. Reeves, J.J. Ritch, S. Zeitlin, N. Aronin, and M. Difiglia A function of huntingtin in guanine nucleotide exchange on Rab11 Neuroreport 19 2008 1643 1647
64. R. Truant, R. Atwal, and A. Burtnik Hypothesis: Huntingtin may function in membrane association and vesicular trafficking Biochem. Cell Biol. 84 2006 912 917 (Pubitemid 46450691)
65. J. Lee, B. Kosaras, S.J. Del Signore, K. Cormier, A. McKee, R.R. Ratan, N.W. Kowall, and H. Ryu Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice Acta Neuropathol. 121 2011 487 498
66. M.A. Sorolla, G. Reverter-Branchat, J. Tamarit, I. Ferrer, J. Ros, and E. Cabiscol Proteomic and oxidative stress analysis in human brain samples of Huntington disease Free Radic. Biol. Med. 45 2008 667 678
67. C.M. Chen, Y.R. Wu, M.L. Cheng, J.L. Liu, Y.M. Lee, P.W. Lee, B.W. Soong, and D.T. Chiu Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients Biochem. Biophys. Res. Commun. 359 2007 335 340 (Pubitemid 46880509)
68. D.W. Cleveland, and J.D. Rothstein From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS Nat. Rev. Neurosci. 2 2001 806 819 (Pubitemid 33674062)
69. N. Nirmalananthan, and L. Greensmith Amyotrophic lateral sclerosis: recent advances and future therapies Curr. Opin. Neurol. 18 2005 712 719 (Pubitemid 41669146)
70. W.A. Pedersen, W. Fu, J.N. Keller, W.R. Markesbery, S. Appel, R.G. Smith, E. Kasarskis, and M.P. Mattson Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients Ann. Neurol. 44 1998 819 824 (Pubitemid 28516055)
71. A.C. Bowling, J.B. Schulz, R.H. Brown Jr. , and M.F. Beal Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis J. Neurochem. 61 1993 2322 2325 (Pubitemid 23354097)
72. M.J. Strong, S. Kesavapany, and H.C. Pant The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J. Neuropathol. Exp. Neurol. 64 2005 649 664 (Pubitemid 41177106)
73. C. Panzeri, C. De Palma, A. Martinuzzi, A. Daga, G. De Polo, N. Bresolin, C.C. Miller, E.L. Tudor, E. Clementi, and M.T. Bassi The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function Brain 129 2006 1710 1719 (Pubitemid 43999405)
74. J.D. Topp, D.S. Carney, and B.F. Horazdovsky Biochemical characterization of alsin, a Rab5 and Rac1 guanine nucleotide exchange factor Methods Enzymol. 403 2005 261 276 (Pubitemid 43216913)
75. M. Hirano, C.M. Quinzii, H. Mitsumoto, A.P. Hays, J. Kirk Roberts, P. Richard, and L.P. Rowland Senataxin mutations and amyotrophic lateral sclerosis Amyotroph. Lateral Scler. 12 2011 223 227
76. A. Suraweera, Y. Lim, R. Woods, G.W. Birrell, T. Nasim, O.J. Becherel, and M.F. Lavin Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation Hum. Mol. Genet. 18 2009 3384 3396
77. L. Helmuth Detangling Alzheimer's disease: new insights into the biological bases of the most common cause of dementia are pointing to better diagnostics and possible therapeutics Sci. Aging Knowledge Environ. 2003 2003 oa2
78. R. Yaari, and J. Corey-Bloom Alzheimer's disease Semin. Neurol. 27 2007 32 41 (Pubitemid 46239037)
79. N. Loncarevic, E. Mehmedika-Sulic, A. Alajbegovic, and A. Kucukalic The neurologist role in diagnostics and therapy of the Alzheimer's disease Med. Arh. 59 2005 106 109
80. R. Katzman Alzheimer's disease as an age-dependent disorder Ciba Found. Symp. 134 1988 69 85
81. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Consensus recommendations for the postmortem diagnosis of Alzheimer's disease Neurobiol. Aging 18 1997 S1 S2
82. A.J. Jak, W.S. Houston, B.J. Nagel, J. Corey-Bloom, and M.W. Bondi Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults Dement. Geriatr. Cogn. Disord. 23 2007 382 389 (Pubitemid 46897174)
83. K.A. Jellinger, W. Paulus, C. Wrocklage, and I. Litvan Traumatic brain injury as a risk factor for Alzheimer disease: comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype BMC Neurol. 1 2001 3
84. J.A. Mortimer, A.R. Borenstein, K.M. Gosche, and D.A. Snowdon Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression J. Geriatr. Psychiatry Neurol. 18 2005 218 223 (Pubitemid 41736387)
85. B. Kuhla, C. Haase, K. Flach, H.J. Luth, T. Arendt, and G. Munch Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation J. Biol. Chem. 282 2007 6984 6991 (Pubitemid 47093635)
86. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, W.R. Markesbery, and D.A. Butterfield The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42 J. Neurochem. 78 2001 413 416 (Pubitemid 32664423)
87. M.A. Lovell, C. Xie, and W.R. Markesbery Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures Neurobiol. Aging 22 2001 187 194 (Pubitemid 32162967)
88. L.T. McGrath, B.M. McGleenon, S. Brennan, D. McColl, I.S. Mc, and A.P. Passmore Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde QJM 94 2001 485 490 (Pubitemid 32894467)
89. W.R. Markesbery, and M.A. Lovell Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiol. Aging 19 1998 33 36 (Pubitemid 28167792)
90. M.L. Selley, D.R. Close, and S.E. Stern The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease Neurobiol. Aging 23 2002 383 388 (Pubitemid 34312021)
91. M.A. Lovell, W.D. Ehmann, M.P. Mattson, and W.R. Markesbery Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease Neurobiol. Aging 18 1997 457 461 (Pubitemid 27497140)
92. M.A. Bradley, W.R. Markesbery, and M.A. Lovell Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease Free Radic. Biol. Med. 48 2010 1570 1576
93. T.T. Reed, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD Brain Res. 1274 2009 66 76
94. D.A. Butterfield, T. Reed, M. Perluigi, C. De Marco, R. Coccia, C. Cini, and R. Sultana Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neurosci. Lett. 397 2006 170 173
95. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK Exp. Neurol. 180 2003 144 155 (Pubitemid 36398169)
96. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 2001 4183 4187 (Pubitemid 32538543)
97. D.A. Butterfield, M.L. Bader Lange, and R. Sultana Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease Biochim. Biophys. Acta 1801 2010 924 929
98. S.W. Scheff, and D.A. Price Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus J. Alzheimers Dis. 9 2006 101 115 (Pubitemid 44253303)
99. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
100. D. Iacono, R. O'Brien, S.M. Resnick, A.B. Zonderman, O. Pletnikova, G. Rudow, Y. An, M.J. West, B. Crain, and J.C. Troncoso Neuronal hypertrophy in asymptomatic Alzheimer disease J. Neuropathol. Exp. Neurol. 67 2008 578 589 (Pubitemid 351787084)
101. M.J. West, C.H. Kawas, W.F. Stewart, G.L. Rudow, and J.C. Troncoso Hippocampal neurons in pre-clinical Alzheimer's disease Neurobiol. Aging 25 2004 1205 1212 (Pubitemid 39094023)
102. R.J. O'Brien, S.M. Resnick, A.B. Zonderman, L. Ferrucci, B.J. Crain, O. Pletnikova, G. Rudow, D. Iacono, M.A. Riudavets, I. Driscoll, D.L. Price, L.J. Martin, and J.C. Troncoso Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA) J. Alzheimers Dis. 18 2009 665 675
103. G. Lyubartseva, J.L. Smith, W.R. Markesbery, and M.A. Lovell Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain Brain Pathol. 20 2010 343 350
104. M.A. Bradley, S. Xiong-Fister, W.R. Markesbery, M.A. Lovell, Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression, Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2010.08.016.
105. R.C. Petersen Mild cognitive impairment as a diagnostic entity J. Intern. Med. 256 2004 183 194 (Pubitemid 39222988)
106. F. Portet, P.J. Ousset, and J. Touchon What is a mild cognitive impairment? Rev. Prat. 55 2005 1891 1894 (Pubitemid 41711564)
107. A. Economou, S.G. Papageorgiou, C. Karageorgiou, and D. Vassilopoulos Nonepisodic memory deficits in amnestic MCI Cogn. Behav. Neurol. 20 2007 99 106 (Pubitemid 46905205)
108. D.P. Devanand, G. Pradhaban, X. Liu, A. Khandji, S. De Santi, S. Segal, H. Rusinek, G.H. Pelton, L.S. Honig, R. Mayeux, Y. Stern, M.H. Tabert, and M.J. de Leon Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease Neurology 68 2007 828 836 (Pubitemid 46568534)
109. C.R. Jack Jr. , R.C. Petersen, Y.C. Xu, P.C. O'Brien, G.E. Smith, R.J. Ivnik, B.F. Boeve, S.C. Waring, E.G. Tangalos, and E. Kokmen Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 52 1999 1397 1403 (Pubitemid 29190530)
110. J. Barnes, A.K. Godbolt, C. Frost, R.G. Boyes, B.F. Jones, R.I. Scahill, M.N. Rossor, and N.C. Fox Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD Neurobiol. Aging 28 2007 20 28 (Pubitemid 44791643)
111. A.T. Du, N. Schuff, D. Amend, M.P. Laakso, Y.Y. Hsu, W.J. Jagust, K. Yaffe, J.H. Kramer, B. Reed, D. Norman, H.C. Chui, and M.W. Weiner Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease J. Neurol. Neurosurg. Psychiatry 71 2001 441 447 (Pubitemid 32906865)
112. A.T. Du, N. Schuff, J.H. Kramer, S. Ganzer, X.P. Zhu, W.J. Jagust, B.L. Miller, B.R. Reed, D. Mungas, K. Yaffe, H.C. Chui, and M.W. Weiner Higher atrophy rate of entorhinal cortex than hippocampus in AD Neurology 62 2004 422 427 (Pubitemid 38200854)
113. K. Mevel, G. Chetelat, B. Desgranges, and F. Eustache Alzheimer's disease, hippocampus and neuroimaging Encéphale 32 2006 S1149 S1154
114. E. Mori Hippocampal atrophy and memory disturbance No To Shinkei 57 2005 1067 1078
115. F. Maioli, M. Coveri, P. Pagni, C. Chiandetti, C. Marchetti, R. Ciarrocchi, C. Ruggero, V. Nativio, A. Onesti, C. D'Anastasio, and V. Pedone Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit Arch. Gerontol. Geriatr. 44 Suppl. 1 2007 233 241 (Pubitemid 46290581)
116. L. Rozzini, B.V. Chilovi, M. Conti, E. Bertoletti, I. Delrio, M. Trabucchi, and A. Padovani Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration Int. J. Geriatr. Psychiatry 22 2007 1217 1222 (Pubitemid 350285426)
117. R.C. Petersen Mild cognitive impairment: transition between aging and Alzheimer's disease Neurologia 15 2000 93 101 (Pubitemid 30340226)
118. A. Ciammola, J. Sassone, M. Cannella, S. Calza, B. Poletti, L. Frati, F. Squitieri, and V. Silani Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 2007 574 577 (Pubitemid 46983172)
119. J. Garcia de Yebenes, J. Yebenes, and M.A. Mena Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease Neurotox. Res. 2 2000 115 137
120. G.J. Siegel, and N.B. Chauhan Neurotrophic factors in Alzheimer's and Parkinson's disease brain Brain Res. Brain Res. Rev. 33 2000 199 227
121. S.X. Bamji, B. Rico, N. Kimes, and L.F. Reichardt BDNF mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin-beta-catenin interactions J. Cell Biol. 174 2006 289 299 (Pubitemid 44079863)
122. N. Durany, T. Michel, J. Kurt, F.F. Cruz-Sanchez, J. Cervas-Navarro, and P. Riederer Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains Int. J. Dev. Neurosci. 18 2000 807 813 (Pubitemid 32037055)
123. T.I. Williams, B.C. Lynn, W.R. Markesbery, and M.A. Lovell Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease Neurobiol. Aging 27 2006 1094 1099 (Pubitemid 43850642)
124. D. Pratico, C.M. Clark, F. Liun, J. Rokach, V.Y. Lee, and J.Q. Trojanowski Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease Arch. Neurol. 59 2002 972 976 (Pubitemid 34640757)
125. W.R. Markesbery, R.J. Kryscio, M.A. Lovell, and J.D. Morrow Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment Ann. Neurol. 58 2005 730 735 (Pubitemid 41552548)
126. T.F. Farrow, S.N. Thiyagesh, I.D. Wilkinson, R.W. Parks, L. Ingram, and P.W. Woodruff Fronto-temporal-lobe atrophy in early-stage Alzheimer's disease identified using an improved detection methodology Psychiatry Res. 155 2007 11 19 (Pubitemid 46578288)
127. W.R. Markesbery, F.A. Schmitt, R.J. Kryscio, D.G. Davis, C.D. Smith, and D.R. Wekstein Neuropathologic substrate of mild cognitive impairment Arch. Neurol. 63 2006 38 46 (Pubitemid 43063860)
128. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann. Neurol. 27 1990 457 464 (Pubitemid 20149963)
129. A. Casado, M. Encarnacion Lopez-Fernandez, M. Concepcion Casado, and R. de La Torre Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias Neurochem. Res. 33 2008 450 458 (Pubitemid 351230446)
130. T.J. Montine, J. Quinn, J. Kaye, and J.D. Morrow F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease J. Mol. Neurosci. 33 2007 114 119 (Pubitemid 47574948)
131. M.R. Wilkins, J.C. Sanchez, K.L. Williams, and D.F. Hochstrasser Current challenges and future applications for protein maps and post-translational vector maps in proteome projects Electrophoresis 17 1996 830 838 (Pubitemid 26000777)
132. P. Davidsson, and M. Sjogren The use of proteomics in biomarker discovery in neurodegenerative diseases Dis. Markers 21 2005 81 92 (Pubitemid 40875152)
133. D. Galasko Biomarkers for Alzheimer's disease-clinical needs and application J. Alzheimers Dis. 8 2005 339 346
134. A. De Iuliis, J. Grigoletto, A. Recchia, P. Giusti, and P. Arslan A proteomic approach in the study of an animal model of Parkinson's disease Clin. Chim. Acta 357 2005 202 209 (Pubitemid 40894638)
135. M. Basso, S. Giraudo, D. Corpillo, B. Bergamasco, L. Lopiano, and M. Fasano Proteome analysis of human substantia nigra in Parkinson's disease Proteomics 4 2004 3943 3952 (Pubitemid 39657469)
136. J. Jin, C. Hulette, Y. Wang, T. Zhang, C. Pan, R. Wadhwa, and J. Zhang Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease Mol. Cell. Proteomics 5 2006 1193 1204 (Pubitemid 44103391)
137. W.R. Gibb, and A.J. Lees The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease Neuropathol. Appl. Neurobiol. 15 1989 27 44 (Pubitemid 19074096)
138. M.S. Jeong, and J.H. Kang Acrolein, the toxic endogenous aldehyde, induces neurofilament-L aggregation BMB Rep. 41 2008 635 639
139. T. Wataya, A. Nunomura, M.A. Smith, S.L. Siedlak, P.L. Harris, S. Shimohama, L.I. Szweda, M.A. Kaminski, J. Avila, D.L. Price, D.W. Cleveland, L.M. Sayre, and G. Perry High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal J. Biol. Chem. 277 2002 4644 4648 (Pubitemid 34968493)
140. M. Fratelli, H. Demol, M. Puype, S. Casagrande, P. Villa, I. Eberini, J. Vandekerckhove, E. Gianazza, and P. Ghezzi Identification of proteins undergoing glutathionylation in oxidatively stressed hepatocytes and hepatoma cells Proteomics 3 2003 1154 1161 (Pubitemid 36929537)
141. S.W. Kang, I.C. Baines, and S.G. Rhee Characterization of a mammalian peroxiredoxin that contains one conserved cysteine J. Biol. Chem. 273 1998 6303 6311 (Pubitemid 28144720)
142. F.M. Low, M.B. Hampton, A.V. Peskin, and C.C. Winterbourn Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte Blood 109 2007 2611 2617 (Pubitemid 46425910)
143. T. Ishii, and T. Yanagawa Stress-induced peroxiredoxins Subcell. Biochem. 44 2007 375 384
144. Z.A. Wood, E. Schroder, J. Robin Harris, and L.B. Poole Structure, mechanism and regulation of peroxiredoxins Trends Biochem. Sci. 28 2003 32 40 (Pubitemid 36051004)
145. H.A. Woo, W. Jeong, T.S. Chang, K.J. Park, S.J. Park, J.S. Yang, and S.G. Rhee Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-Cys peroxiredoxins J. Biol. Chem. 280 2005 3125 3128 (Pubitemid 40223772)
146. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 Suppl. 3 2003 S26 S36 discussion S36-28
147. I. Ferrer, E. Perez, E. Dalfo, and M. Barrachina Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease Neurosci. Lett. 415 2007 205 209 (Pubitemid 46420396)
148. C.G. Giraudo, A. Garcia-Diaz, W.S. Eng, A. Yamamoto, T.J. Melia, and J.E. Rothman Distinct domains of complexins bind SNARE complexes and clamp fusion in vitro J. Biol. Chem. 283 2008 21211 21219
149. P. Jenner, D.T. Dexter, J. Sian, A.H. Schapira, and C.D. Marsden Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group Ann. Neurol. 32 1992 S82 S87 Suppl.
150. J.Y. Li, N. Popovic, and P. Brundin The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies NeuroRx 2 2005 447 464 (Pubitemid 41444878)
151. C. Turner, and A.H. Schapira Mitochondrial matters of the brain: the role in Huntington's disease J. Bioenerg. Biomembr. 42 2010 193 198
152. C. Zabel, L. Mao, B. Woodman, M. Rohe, M.A. Wacker, Y. Klare, A. Koppelstatter, G. Nebrich, O. Klein, S. Grams, A. Strand, R. Luthi-Carter, D. Hartl, J. Klose, and G.P. Bates A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for Huntington disease Mol. Cell. Proteomics 8 2009 720 734
153. M. Perluigi, H.F. Poon, W. Maragos, W.M. Pierce, J.B. Klein, V. Calabrese, C. Cini, C. De Marco, and D.A. Butterfield Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease Mol. Cell. Proteomics 4 2005 1849 1861 (Pubitemid 41830180)
154. L. Petrozzi, G. Ricci, N.J. Giglioli, G. Siciliano, and M. Mancuso Mitochondria and neurodegeneration Biosci. Rep. 27 2007 87 104 (Pubitemid 46940938)
155. K. Josefsen, S.M. Nielsen, A. Campos, T. Seifert, L. Hasholt, J.E. Nielsen, A. Norremolle, N.H. Skotte, N.H. Secher, and B. Quistorff Reduced gluconeogenesis and lactate clearance in Huntington's disease Neurobiol. Dis. 40 2010 656 662
156. T. Ekegren, J. Hanrieder, S.M. Aquilonius, and J. Bergquist Focused proteomics in post-mortem human spinal cord J. Proteome Res. 5 2006 2364 2371 (Pubitemid 44330829)
157. H.F. Poon, M. Frasier, N. Shreve, V. Calabrese, B. Wolozin, and D.A. Butterfield Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice-a model of familial Parkinson's disease Neurobiol. Dis. 18 2005 492 498 (Pubitemid 40332708)
158. A. Castegna, M. Aksenov, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 J. Neurochem. 82 2002 1524 1532
159. S.M. Eliuk, M.B. Renfrow, E.M. Shonsey, S. Barnes, and H. Kim Active site modifications of the brain isoform of creatine kinase by 4-hydroxy-2-nonenal correlate with reduced enzyme activity: mapping of modified sites by Fourier transform-ion cyclotron resonance mass spectrometry Chem. Res. Toxicol. 20 2007 1260 1268 (Pubitemid 47548294)
160. T. Ishii, E. Tatsuda, S. Kumazawa, T. Nakayama, and K. Uchida Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase Biochemistry 42 2003 3474 3480 (Pubitemid 36368641)
161. J. Middeldorp, and E.M. Hol GFAP in health and disease Prog. Neurobiol. 93 2011 421 443
162. P.G. Sullivan, A.G. Rabchevsky, P.C. Waldmeier, and J.E. Springer Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J. Neurosci. Res. 79 2005 231 239 (Pubitemid 40116440)
163. S.A. Barrientos, N.W. Martinez, S. Yoo, J.S. Jara, S. Zamorano, C. Hetz, J.L. Twiss, J. Alvarez, and F.A. Court Axonal degeneration is mediated by the mitochondrial permeability transition pore J. Neurosci. 31 2011 966 978
164. A.D. Chacko, F. Liberante, I. Paul, D.B. Longley, and D.A. Fennell Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8 BMC Cancer 10 2010 380
165. V. Shoshan-Barmatz, V. De Pinto, M. Zweckstetter, Z. Raviv, N. Keinan, and N. Arbel VDAC, a multi-functional mitochondrial protein regulating cell life and death Mol. Aspects Med. 31 2010 227 285
166. D. Han, F. Antunes, R. Canali, D. Rettori, and E. Cadenas Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol J. Biol. Chem. 278 2003 5557 5563 (Pubitemid 36800797)
167. V. Calabrese, G. Scapagnini, C. Colombrita, A. Ravagna, G. Pennisi, A.M. Giuffrida Stella, F. Galli, and D.A. Butterfield Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach Amino Acids 25 2003 437 444 (Pubitemid 38041278)
168. M. Perluigi, H. Fai Poon, K. Hensley, W.M. Pierce, J.B. Klein, V. Calabrese, C. De Marco, and D.A. Butterfield Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis Free Radic. Biol. Med. 38 2005 960 968 (Pubitemid 40321087)
169. N. Hamajima, K. Matsuda, S. Sakata, N. Tamaki, M. Sasaki, and M. Nonaka A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution Gene 180 1996 157 163 (Pubitemid 26417923)
170. Y. Kato, N. Hamajima, H. Inagaki, N. Okamura, T. Koji, M. Sasaki, and M. Nonaka Post-meiotic expression of the mouse dihydropyrimidinase-related protein 3 (DRP-3) gene during spermiogenesis Mol. Reprod. Dev. 51 1998 105 111 (Pubitemid 28372964)
171. Y. Goshima, F. Nakamura, P. Strittmatter, and S.M. Strittmatter Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33 Nature 376 1995 509 514
172. N. Arimura, N. Inagaki, K. Chihara, C. Menager, N. Nakamura, M. Amano, A. Iwamatsu, Y. Goshima, and K. Kaibuchi Phosphorylation of collapsin response mediator protein-2 by Rho-kinase: evidence for two separate signaling pathways for growth cone collapse J. Biol. Chem. 275 2000 23973 23980 (Pubitemid 30624686)
173. Y. Fukata, T.J. Itoh, T. Kimura, C. Menager, T. Nishimura, T. Shiromizu, H. Watanabe, N. Inagaki, A. Iwamatsu, H. Hotani, and K. Kaibuchi CRMP-2 binds to tubulin heterodimers to promote microtubule assembly Nat. Cell Biol. 4 2002 583 591
174. Y. Gu, and Y. Ihara Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules J. Biol. Chem. 275 2000 17917 17920 (Pubitemid 30414732)
175. M.R. Jain, W.W. Ge, S. Elkabes, and H. Li Amyotrophic lateral sclerosis: protein chaperone dysfunction revealed by proteomic studies of animal models Proteomics Clin. Appl. 2 2008 670 684 (Pubitemid 351772023)
176. T. Massignan, F. Casoni, M. Basso, P. Stefanazzi, E. Biasini, M. Tortarolo, M. Salmona, E. Gianazza, C. Bendotti, and V. Bonetto Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse Biochem. Biophys. Res. Commun. 353 2007 719 725 (Pubitemid 46048729)
177. K. Hellberg, P.A. Grimsrud, A.C. Kruse, L.J. Banaszak, D.H. Ohlendorf, and D.A. Bernlohr X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal Protein Sci. 19 2010 1480 1489
178. +-ATPase Free Radic. Biol. Med. 20 1996 215 223 (Pubitemid 26021879)
179. M.J. West, P.D. Coleman, D.G. Flood, and J.C. Troncoso Differential neuronal loss in the hippocampus in normal aging and in patients with Alzheimer disease Ugeskr. Laeger 157 1995 3190 3193
180. C.D. Aluise, R.A. Robinson, J. Cai, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer disease: insights into memory loss in MCI J. Alzheimers Dis. 23 2010 257 269
181. W. Meier-Ruge, C. Bertoni-Freddari, and P. Iwangoff Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease Gerontology 40 1994 246 252 (Pubitemid 24221035)
182. S.R. Heller, and I.A. Macdonald The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness Diabet. Med. 13 1996 607 615 (Pubitemid 26232500)
183. S. Hoyer Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease Acta Neurol. Scand. 165 1996 18 24 (Pubitemid 26143163)
184. S. Hoyer Glucose metabolism and insulin receptor signal transduction in Alzheimer disease Eur. J. Pharmacol. 490 2004 115 125 (Pubitemid 38482165)
185. S.I. Rapoport Functional brain imaging in the resting state and during activation in Alzheimer's disease: implications for disease mechanisms involving oxidative phosphorylation Ann. N. Y. Acad. Sci. 893 1999 138 153 (Pubitemid 30038073)
186. D. Boyd-Kimball, A. Castegna, R. Sultana, H.F. Poon, R. Petroze, B.C. Lynn, J.B. Klein, and D.A. Butterfield Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease Brain Res. 1044 2005 206 215 (Pubitemid 40693453)
187. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J. Neurochem. 85 2003 1394 1401 (Pubitemid 36702552)
188. H.F. Poon, S.A. Farr, V. Thongboonkerd, B.C. Lynn, W.A. Banks, J.E. Morley, J.B. Klein, and D.A. Butterfield Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders Neurochem. Int. 46 2005 159 168 (Pubitemid 41556623)
189. R. Sultana, M. Perluigi, and D.A. Butterfield Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42) J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 833 2006 3 11
190. R. Sultana, D. Boyd-Kimball, H.F. Poon, J. Cai, W.M. Pierce, J.B. Klein, M. Merchant, W.R. Markesbery, and D.A. Butterfield Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD Neurobiol. Aging 27 2006 1564 1576 (Pubitemid 44344840)
191. D.A. Butterfield, H.F. Poon, D. St Clair, J.N. Keller, W.M. Pierce, J.B. Klein, and W.R. Markesbery Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease Neurobiol. Dis. 22 2006 223 232
192. A. Castegna, C.M. Lauderback, H. Mohmmad-Abdul, and D.A. Butterfield Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease Brain Res. 1004 2004 193 197 (Pubitemid 38368075)
193. L.P. Sousa, B.M. Silva, B.S. Brasil, S.V. Nogueira, P.C. Ferreira, E.G. Kroon, K. Kato, and C.A. Bonjardim Plasminogen/plasmin regulates α-enolase expression through the MEK/ERK pathway Biochem. Biophys. Res. Commun. 337 2005 1065 1071 (Pubitemid 41505234)
194. M.D. Ledesma, J.S. Da Silva, K. Crassaerts, A. Delacourte, B. De Strooper, and C.G. Dotti Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains EMBO Rep. 1 2000 530 535
195. H.M. Tucker, M. Kihiko-Ehmann, S. Wright, R.E. Rydel, and S. Estus Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition J. Neurochem. 75 2000 2172 2177
196. J.N. Keller, Z. Pang, J.W. Geddes, J.G. Begley, A. Germeyer, G. Waeg, and M.P. Mattson Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal J. Neurochem. 69 1997 273 284 (Pubitemid 27274182)
197. M.P. Mattson, and S.L. Chan Neuronal and glial calcium signaling in Alzheimer's disease Cell Calcium 34 2003 385 397 (Pubitemid 37021231)
198. M.L. Bader Lange, G. Cenini, M. Piroddi, H.M. Abdul, R. Sultana, F. Galli, M. Memo, and D.A. Butterfield Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease Neurobiol. Dis. 29 2008 456 464
199. J.W. Geddes, Z. Pang, and D.H. Wiley Hippocampal damage and cytoskeletal disruption resulting from impaired energy metabolism: implications for Alzheimer disease Mol. Chem. Neuropathol. 28 1996 65 74 (Pubitemid 26275052)
200. C. Messier, and M. Gagnon Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes Behav. Brain Res. 75 1996 1 11 (Pubitemid 26076738)
201. M. Vanhanen, and H. Soininen Glucose intolerance, cognitive impairment and Alzheimer's disease Curr. Opin. Neurol. 11 1998 673 677 (Pubitemid 28561204)
202. Z. Duan, D.E. Lamendola, R.Z. Yusuf, R.T. Penson, F.I. Preffer, and M.V. Seiden Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype Anticancer Res. 22 2002 1933 1941 (Pubitemid 34857007)
203. M.A. Lovell, C. Xie, and W.R. Markesbery Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease Neurology 51 1998 1562 1566 (Pubitemid 28565232)
204. R. Sultana, and D.A. Butterfield Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products Neurochem. Res. 29 2004 2215 2220 (Pubitemid 40036893)
205. S.A. Akman, T.R. O'Connor, and H. Rodriguez Mapping oxidative DNA damage and mechanisms of repair Ann. N. Y. Acad. Sci. 899 2000 88 102 (Pubitemid 30352778)
206. K. Kida, T. Nishio, K. Nagai, H. Matsuda, and H. Nakagawa Gluconeogenesis in the kidney in vivo in fed rats: circadian change and substrate specificity J. Biochem. 91 1982 755 760 (Pubitemid 12116983)
207. M. Perluigi, R. Sultana, G. Cenini, F. Di Domenico, M. Memo, W.M. Pierce, R. Coccia, and D.A. Butterfield Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: role of lipid peroxidation in Alzheimer's disease pathogenesis Proteomics Clin. Appl. 3 2009 682 693
208. D.A. Butterfield Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain Free Radic. Res. 36 2002 1307 1313 (Pubitemid 35469517)
209. D.A. Butterfield, J. Drake, C. Pocernich, and A. Castegna Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends Mol. Med. 7 2001 548 554 (Pubitemid 33127140)
210. D.A. Butterfield, and C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress Free Radic. Biol. Med. 32 2002 1050 1060 (Pubitemid 34603342)
211. D.A. Butterfield, M. Perluigi, and R. Sultana Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics Eur. J. Pharmacol. 545 2006 39 50 (Pubitemid 44215876)
212. Z.H. Chen, and E. Niki 4-Hydroxynonenal (4-HNE) has been widely accepted as an inducer of oxidative stress: is this the whole truth about it or can 4-HNE also exert protective effects? IUBMB Life 58 2006 372 373 (Pubitemid 43880031)
213. S. Hauptmann, U. Keil, I. Scherping, A. Bonert, A. Eckert, and W.E. Muller Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease Exp. Gerontol. 41 2006 668 673 (Pubitemid 43866354)
214. S. Reix, N. Mechawar, S.A. Susin, R. Quirion, and S. Krantic Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease Neurobiol. Aging 28 2007 351 356 (Pubitemid 46177383)
215. S.H. Kim, R. Vlkolinsky, N. Cairns, and G. Lubec Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome Cell. Mol. Life Sci. 57 2000 1810 1816
216. W.E. Muller, A. Eckert, C. Kurz, G.P. Eckert, and K. Leuner Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects Mol. Neurobiol. 41 2010 159 171
217. M. Mancuso, F. Coppede, L. Migliore, G. Siciliano, and L. Murri Mitochondrial dysfunction, oxidative stress and neurodegeneration J. Alzheimers Dis. 10 2006 59 73 (Pubitemid 44401367)
218. X. Zhu, H.G. Lee, G. Casadesus, J. Avila, K. Drew, G. Perry, and M.A. Smith Oxidative imbalance in Alzheimer's disease Mol. Neurobiol. 31 2005 205 217 (Pubitemid 41271204)
219. B. Halliwell Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97 2006 1634 1658 (Pubitemid 43873658)
220. W.R. Markesbery Oxidative stress hypothesis in Alzheimer's disease Free Radic. Biol. Med. 23 1997 134 147 (Pubitemid 27217017)
221. D.A. Butterfield, H.M. Abdul, S. Newman, and T. Reed Redox proteomics in some age-related neurodegenerative disorders or models thereof NeuroRx 3 2006 344 357 (Pubitemid 43946717)
222. F. Battaini, A. Pascale, L. Lucchi, G.M. Pasinetti, and S. Govoni Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients Exp. Neurol. 159 1999 559 564 (Pubitemid 29485243)
223. J.E. Goldman Immunocytochemical studies of actin localization in the central nervous system J. Neurosci. 3 1983 1952 1962 (Pubitemid 14233757)
224. E. Masliah, M. Mallory, L. Hansen, R. DeTeresa, M. Alford, and R. Terry Synaptic and neuritic alterations during the progression of Alzheimer's disease Neurosci. Lett. 174 1994 67 72 (Pubitemid 24205235)
225. J.A. Doorn, E. Maser, A. Blum, D.J. Claffey, and D.R. Petersen Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal Biochemistry 43 2004 13106 13114 (Pubitemid 39366059)
226. U. Oppermann Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology Annu. Rev. Pharmacol. Toxicol. 47 2007 293 322
227. B. Balcz, L. Kirchner, N. Cairns, M. Fountoulakis, and G. Lubec Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease J. Neural Transm. Suppl. 61 2001 193 201 (Pubitemid 38085082)
228. Z.H. Chen, Y. Saito, Y. Yoshida, A. Sekine, N. Noguchi, and E. Niki 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2 J. Biol. Chem. 280 2005 41921 41927 (Pubitemid 43023161)
229. N. Lemieux, B. Malfoy, and G.L. Forrest Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells Genomics 15 1993 169 172 (Pubitemid 23079585)
230. G.L. Forrest, and B. Gonzalez Carbonyl reductase Chem. Biol. Interact. 129 2000 21 40 (Pubitemid 32061052)
231. J.R. Korenberg, C. Bradley, and C.M. Disteche Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis Am. J. Hum. Genet. 50 1992 294 302
232. A. Petronis Alzheimer's disease and down syndrome: from meiosis to dementia Exp. Neurol. 158 1999 403 413 (Pubitemid 29382830)
233. M. Ling, F. Merante, H.S. Chen, C. Duff, A.M. Duncan, and B.H. Robinson The human mitochondrial elongation factor tu (EF-Tu) gene: cDNA sequence, genomic localization, genomic structure, and identification of a pseudogene Gene 197 1997 325 336 (Pubitemid 27399908)
234. S. Orrenius, D.H. Burgess, M.B. Hampton, and B. Zhivotovsky Mitochondria as the focus of apoptosis research Cell Death Differ. 4 1997 427 428
235. J.L. Vayssiere, L. Cordeau-Lossouarn, J.C. Larcher, M. Basseville, F. Gros, and B. Croizat Participation of the mitochondrial genome in the differentiation of neuroblastoma cells In Vitro Cell. Dev. Biol. 28A 1992 763 772 (Pubitemid 23054050)
236. T.V. Pestova, and C.U. Hellen The structure and function of initiation factors in eukaryotic protein synthesis Cell. Mol. Life Sci. 57 2000 651 674 (Pubitemid 30311435)
237. J.E. Thompson, M.T. Hopkins, C. Taylor, and T.W. Wang Regulation of senescence by eukaryotic translation initiation factor 5A: implications for plant growth and development Trends Plant Sci. 9 2004 174 179 (Pubitemid 38448756)
238. M.E. Tome, S.M. Fiser, C.M. Payne, and E.W. Gerner Excess putrescine accumulation inhibits the formation of modified eukaryotic initiation factor 5A (eIF-5A) and induces apoptosis Biochem. J. 328 1997 847 854 (Pubitemid 28005785)
239. R.C. Chang, A.K. Wong, H.K. Ng, and J. Hugon Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease Neuroreport 13 2002 2429 2432 (Pubitemid 36143538)
240. I. Ferrer Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease Neuropathol. Appl. Neurobiol. 28 2002 441 451 (Pubitemid 35425597)
241. E.M. Sajdel-Sulkowska, and C.A. Marotta Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex Science 225 1984 947 949 (Pubitemid 14064179)
242. Q. Ding, W.R. Markesbery, Q. Chen, F. Li, and J.N. Keller Ribosome dysfunction is an early event in Alzheimer's disease J. Neurosci. 25 2005 9171 9175 (Pubitemid 41500825)
243. F. Di Domenico, R. Sultana, G.F. Tiu, N.N. Scheff, M. Perluigi, C. Cini, and D.A. Butterfield Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease Brain Res. 1333 2010 72 81
244. J. Magrane, R.C. Smith, K. Walsh, and H.W. Querfurth Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons J. Neurosci. 24 2004 1700 1706 (Pubitemid 38240967)
245. J.N. Keller, K.B. Hanni, and W.R. Markesbery Impaired proteasome function in Alzheimer's disease J. Neurochem. 75 2000 436 439 (Pubitemid 30418211)
246. K. Ojika, Y. Tsugu, S. Mitake, Y. Otsuka, and E. Katada NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro Brain Res. Dev. Brain Res. 106 1998 173 180 (Pubitemid 28168483)
247. A. Jouvenceau, P. Dutar, and J.M. Billard Alteration of NMDA receptor-mediated synaptic responses in CA1 area of the aged rat hippocampus: contribution of GABAergic and cholinergic deficits Hippocampus 8 1998 627 637 (Pubitemid 29010190)
248. P. Davies, and R.D. Terry Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type Neurobiol. Aging 2 1981 9 14 (Pubitemid 11082130)
249. B.M. Davis, R.C. Mohs, B.S. Greenwald, A.A. Mathe, C.A. Johns, T.B. Horvath, and K.L. Davis Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies J. Am. Geriatr. Soc. 33 1985 741 748 (Pubitemid 16183969)
250. E.K. Perry, R.H. Perry, C.J. Smith, D. Purohit, J. Bonham, D.J. Dick, J.M. Candy, J.A. Edwardson, and A. Fairbairn Cholinergic receptors in cognitive disorders Can. J. Neurol. Sci. 13 1986 521 527 (Pubitemid 17212714)
251. M.N. Rossor, L.L. Iversen, A.J. Johnson, C.Q. Mountjoy, and M. Roth Cholinergic deficit in frontal cerebral cortex in Alzheimer's disease is age dependent Lancet 2 1981 1422
252. P.T. Francis, A.M. Palmer, M. Snape, and G.K. Wilcock The cholinergic hypothesis of Alzheimer's disease: a review of progress J. Neurol. Neurosurg. Psychiatry 66 1999 137 147 (Pubitemid 29103513)
253. S. Sperandio, K.S. Poksay, B. Schilling, D. Crippen, B.W. Gibson, and D.E. Bredesen Identification of new modulators and protein alterations in non-apoptotic programmed cell death J. Cell. Biochem. 111 2010 1401 1412
254. A.J. George, R.M. Holsinger, C.A. McLean, S.S. Tan, H.S. Scott, T. Cardamone, R. Cappai, C.L. Masters, and Q.X. Li Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease Neurobiol. Aging 27 2006 614 623 (Pubitemid 43290530)
255. J. Olah, F. Orosz, L.G. Puskas, L. Hackler Jr. , M. Horanyi, L. Polgar, S. Hollan, and J. Ovadi Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels Biochem. J. 392 2005 675 683 (Pubitemid 43022748)
256. F. Orosz, J. Olah, and J. Ovadi Triosephosphate isomerase deficiency: facts and doubts IUBMB Life 58 2006 703 715 (Pubitemid 46895567)
257. P. Iwangoff, R. Armbruster, A. Enz, and W. Meier-Ruge Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases Mech. Ageing Dev. 14 1980 203 209 (Pubitemid 11175996)
258. W. Meier-Ruge, P. Iwangoff, and K. Reichlmeier Neurochemical enzyme changes in Alzheimer's and Pick's disease Arch. Gerontol. Geriatr. 3 1984 161 165 (Pubitemid 14030380)
259. Y. Chen, C. Daosukho, W.O. Opii, D.M. Turner, W.M. Pierce, J.B. Klein, M. Vore, D.A. Butterfield, and D.K. St Clair Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice Free Radic. Biol. Med. 41 2006 1470 1477 (Pubitemid 44466730)
260. H.F. Poon, A. Castegna, S.A. Farr, V. Thongboonkerd, B.C. Lynn, W.A. Banks, J.E. Morley, J.B. Klein, and D.A. Butterfield Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain Neuroscience 126 2004 915 926 (Pubitemid 38780896)
261. S.A. Park, H.W. Park, N.H. Kim, Y.H. Kim, M.J. Kwak, J.S. Shin, and C.W. Kim Effects of Tau on the activity of triose phosphate isomerase (TPI) in brain cells Neurochem. Int. 56 2010 886 892
262. S.Z. Potter, and J.S. Valentine The perplexing role of copper-zinc superoxide dismutase in amyotrophic lateral sclerosis (Lou Gehrig's disease) J. Biol. Inorg. Chem. 8 2003 373 380 (Pubitemid 36578189)
263. M. DiDonato, L. Craig, M.E. Huff, M.M. Thayer, R.M. Cardoso, C.J. Kassmann, T.P. Lo, C.K. Bruns, E.T. Powers, J.W. Kelly, E.D. Getzoff, and J.A. Tainer ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization J. Mol. Biol. 332 2003 601 615 (Pubitemid 37075984)
264. P.B. Stathopulos, J.A. Rumfeldt, G.A. Scholz, R.A. Irani, H.E. Frey, R.A. Hallewell, J.R. Lepock, and E.M. Meiering Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro Proc. Natl. Acad. Sci. U.S.A. 100 2003 7021 7026 (Pubitemid 36706386)
265. T. Gulesserian, R. Seidl, R. Hardmeier, N. Cairns, and G. Lubec Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome J. Investig. Med. 49 2001 41 46 (Pubitemid 32112582)
266. M. Lee, D. Hyun, P. Jenner, and B. Halliwell Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis J. Neurochem. 76 2001 957 965 (Pubitemid 32167369)
267. A.G. Reaume, J.L. Elliott, E.K. Hoffman, N.W. Kowall, R.J. Ferrante, D.F. Siwek, H.M. Wilcox, D.G. Flood, M.F. Beal, R.H. Brown Jr. , R.W. Scott, and W.D. Snider Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury Nat. Genet. 13 1996 43 47 (Pubitemid 26139292)
268. R.M. Lebovitz, H. Zhang, H. Vogel, J. Cartwright Jr. , L. Dionne, N. Lu, S. Huang, and M.M. Matzuk Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice Proc. Natl. Acad. Sci. U.S.A. 93 1996 9782 9787 (Pubitemid 26296686)
269. Y. Li, T.T. Huang, E.J. Carlson, S. Melov, P.C. Ursell, J.L. Olson, L.J. Noble, M.P. Yoshimura, C. Berger, P.H. Chan, D.C. Wallace, and C.J. Epstein Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase Nat. Genet. 11 1995 376 381
270. L.A. MacMillan-Crow, and J.A. Thompson Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite Arch. Biochem. Biophys. 366 1999 82 88 (Pubitemid 29394232)
271. V. Demicheli, C. Quijano, B. Alvarez, and R. Radi Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide Free Radic. Biol. Med. 42 2007 1359 1368 (Pubitemid 46467271)
272. J.N. Keller, M.S. Kindy, F.W. Holtsberg, D.K. St Clair, H.C. Yen, A. Germeyer, S.M. Steiner, A.J. Bruce-Keller, J.B. Hutchins, and M.P. Mattson Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction J. Neurosci. 18 1998 687 697 (Pubitemid 28041905)
273. M.R. Filipovic, D. Stanic, S. Raicevic, M. Spasic, and V. Niketic Consequences of MnSOD interactions with nitric oxide: nitric oxide dismutation and the generation of peroxynitrite and hydrogen peroxide Free Radic. Res. 41 2007 62 72 (Pubitemid 44896875)
274. L.A. Macmillan-Crow, and D.L. Cruthirds Manganese superoxide dismutase in disease Free Radic. Res. 34 2001 325 336
275. J. Tangpong, M.P. Cole, R. Sultana, S. Estus, M. Vore, W. St Clair, S. Ratanachaiyavong, D.K. St Clair, and D.A. Butterfield Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain J. Neurochem. 100 2007 191 201 (Pubitemid 46090774)
276. P. Bubber, V. Haroutunian, G. Fisch, J.P. Blass, and G.E. Gibson Mitochondrial abnormalities in Alzheimer brain: mechanistic implications Ann. Neurol. 57 2005 695 703 (Pubitemid 40628858)
277. W. Op den Velde, and F.C. Stam Some cerebral proteins and enzyme systems in Alzheimer's presenile and senile dementia J. Am. Geriatr. Soc. 24 1976 12 16
278. H. Yoshida, A. Watanabe, and Y. Ihara Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease J. Biol. Chem. 273 1998 9761 9768 (Pubitemid 28183069)
279. R. Weitzdoerfer, M. Fountoulakis, and G. Lubec Aberrant expression of dihydropyrimidinase related proteins-2, -3 and - 4 in fetal Down syndrome brain J. Neural Transm. Suppl. 61 2001 95 107 (Pubitemid 38085075)
280. G. Lubec, M. Nonaka, K. Krapfenbauer, M. Gratzer, N. Cairns, and M. Fountoulakis Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level J. Neural Transm. Suppl. 57 1999 161 177
281. S.J. Baloyannis, V. Costa, I. Mauroudis, D. Psaroulis, S.L. Manolides, and L.S. Manolides Dendritic and spinal pathology in the acoustic cortex in Alzheimer's disease: morphological and morphometric estimation by Golgi technique and electron microscopy Acta Otolaryngol. 127 2007 351 354 (Pubitemid 46572867)
282. P.D. Coleman, and D.G. Flood Neuron numbers and dendritic extent in normal aging and Alzheimer's disease Neurobiol. Aging 8 1987 521 545 (Pubitemid 18006178)
283. H. Fukuyama, M. Ogawa, H. Yamauchi, S. Yamaguchi, J. Kimura, Y. Yonekura, and J. Konishi Altered cerebral energy metabolism in Alzheimer's disease: a PET study J. Nucl. Med. 35 1994 1 6 (Pubitemid 24018423)
284. M.E. Gotz, G. Kunig, P. Riederer, and M.B. Youdim Oxidative stress: free radical production in neural degeneration Pharmacol. Ther. 63 1994 37 122 (Pubitemid 24250150)
285. Z.S. Vexler, A. Wong, C. Francisco, C. Manabat, S. Christen, M. Tauber, D.M. Ferriero, and G. Gregory Fructose-1,6-bisphosphate preserves intracellular glutathione and protects cortical neurons against oxidative stress Brain Res. 960 2003 90 98 (Pubitemid 36044566)
286. R. Sultana, D. Boyd-Kimball, J. Cai, W.M. Pierce, J.B. Klein, M. Merchant, and D.A. Butterfield Proteomics analysis of the Alzheimer's disease hippocampal proteome J. Alzheimers Dis. 11 2007 153 164 (Pubitemid 47010980)
287. A. Gomez, and I. Ferrer Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases J. Neurosci. Res. 87 2009 1002 1013
288. E. Barreiro, J. Gea, M. Di Falco, L. Kriazhev, S. James, and S.N. Hussain Protein carbonyl formation in the diaphragm Am. J. Respir. Cell Mol. Biol. 32 2005 9 17 (Pubitemid 40053299)
289. J. Luo, and R. Shi Acrolein induces oxidative stress in brain mitochondria Neurochem. Int. 46 2005 243 252
290. S.P. Singh, M. Niemczyk, D. Saini, Y.C. Awasthi, L. Zimniak, and P. Zimniak Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice Biochemistry 47 2008 3900 3911 (Pubitemid 351431379)
291. A.H. Schapira Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia Biochim. Biophys. Acta 1410 1999 159 170 (Pubitemid 29078602)
292. C.S. Yarian, I. Rebrin, and R.S. Sohal Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria Biochem. Biophys. Res. Commun. 330 2005 151 156 (Pubitemid 40394947)
293. S.W. Scheff, D.A. Price, F.A. Schmitt, and E.J. Mufson Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment Neurobiol. Aging 27 2006 1372 1384 (Pubitemid 44279897)
294. E. Gadoni, A. Olivero, A. Miglietta, C. Bocca, and L. Gabriel Cytoskeletal modifications induced by 4-hydroxynonenal Cytotechnology 11 Suppl. 1 1993 S62 S64
295. M.D. Neely, A. Boutte, D. Milatovic, and T.J. Montine Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction Brain Res. 1037 2005 90 98 (Pubitemid 40362384)
296. M.D. Neely, K.R. Sidell, D.G. Graham, and T.J. Montine The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin J. Neurochem. 72 1999 2323 2333 (Pubitemid 29242182)
297. D.A. Butterfield, K. Hensley, P. Cole, R. Subramaniam, M. Aksenov, M. Aksenova, P.M. Bummer, B.E. Haley, and J.M. Carney Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease J. Neurochem. 68 1997 2451 2457 (Pubitemid 27218166)
298. K. Hensley, N. Hall, R. Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, S.P. Gabbita, J.F. Wu, and J.M. Carney Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation J. Neurochem. 65 1995 2146 2156
299. J.M. Carney, C.D. Smith, A.M. Carney, and D.A. Butterfield Aging- and oxygen-induced modifications in brain biochemistry and behavior Ann. N. Y. Acad. Sci. 738 1994 44 53
300. K.M. Stuhlmeier, J.J. Kao, P. Wallbrandt, M. Lindberg, B. Hammarstrom, H. Broell, and B. Paigen Antioxidant protein 2 prevents methemoglobin formation in erythrocyte hemolysates Eur. J. Biochem. 270 2003 334 341 (Pubitemid 36114931)
301. J.W. Chen, C. Dodia, S.I. Feinstein, M.K. Jain, and A.B. Fisher 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities J. Biol. Chem. 275 2000 28421 28427
302. M. Salmon, J. Dedessus Le Moutier, F. Wenders, S. Chiarizia, F. Eliaers, J. Remacle, V. Royer, T. Pascal, and O. Toussaint Role of the PLA2-independent peroxiredoxin VI activity in the survival of immortalized fibroblasts exposed to cytotoxic oxidative stress FEBS Lett. 557 2004 26 32 (Pubitemid 38115864)
303. P.J. Lu, G. Wulf, X.Z. Zhou, P. Davies, and K.P. Lu The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein Nature 399 1999 784 788 (Pubitemid 29293174)
304. R. Sultana, D. Boyd-Kimball, H.F. Poon, J. Cai, W.M. Pierce, J.B. Klein, W.R. Markesbery, X.Z. Zhou, K.P. Lu, and D.A. Butterfield Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis Neurobiol. Aging 27 2006 918 925
305. J.H. Power, S. Asad, T.K. Chataway, F. Chegini, J. Manavis, J.A. Temlett, P.H. Jensen, P.C. Blumbergs, and W.P. Gai Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology Acta Neuropathol. 115 2008 611 622
306. Y. Yoshida, A. Yoshikawa, T. Kinumi, Y. Ogawa, Y. Saito, K. Ohara, H. Yamamoto, Y. Imai, and E. Niki Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers Neurobiol. Aging 30 2009 174 185